{"id":632,"date":"2024-01-03T15:37:56","date_gmt":"2024-01-03T21:37:56","guid":{"rendered":"https:\/\/staging.cc-pfizer-seagen.cliquedomains.com\/homepage\/"},"modified":"2026-07-13T14:42:39","modified_gmt":"2026-07-13T19:42:39","slug":"lung-02-clinical-trial-c5751003-pfizer","status":"publish","type":"page","link":"https:\/\/lungcancerstudy.com\/en-gb\/","title":{"rendered":"Homepage"},"content":{"rendered":"
\n\t
\n\t\t\t\t\t
\n\t\t\t\t\n\t\t\t\t
\n
\n
\n

You can support lung cancer research.<\/h1>\n

A clinical trial for people who have not yet been treated for advanced non-small cell lung cancer (NSCLC) is now enrolling. See if you qualify.<\/p>\n <\/div>\n\n

\n \n Explore study locations\n \n \n<\/svg>\n\n <\/a>\n <\/div>\n <\/div>\n<\/div>\n\n\t\t\t\t\t\t\t\t\t
\n
\n <\/picture>\n <\/div>\n
\n <\/picture>\n <\/div>\n <\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\n\t\t\t<\/div>\n\n<\/section>\n
\n\t
\n \n Explore study locations\n \n \n<\/svg>\n\n <\/a>\n <\/div>\n<\/div>\n\n\n\n\n
\n
\n

Learn about a clinical trial for previously treated non-small cell lung cancer (NSCLC)<\/h2>\n\n\n\n

The Be6A LUNG-02 Clinical Trial is evaluating the safety and effectiveness of a study medicine (sigvotatug vedotin) used with a standard therapy (pembrolizumab) in people who have not yet been treated for advanced non-small cell lung cancer (NSCLC).  <\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

Who may participate<\/h2>\n\n\n\n

Deciding to take part in a clinical trial is an important and personal decision. Before you agree to take part, the study team will review all aspects of the clinical trial with you. You will be given a document called an Informed Consent Document (ICD) that provides, in writing, details about the clinical trial including benefits and risks. You will have the opportunity to ask questions and are encouraged to speak to your own doctor to decide if taking part is right for you. <\/p>\n\n\n\n

<\/p>\n\n\n\n

You may be eligible to take part in the clinical trial if you:<\/p>\n\n\n\n